Advertisement
Screener

MUSTANG BIO, INC. (MBIO) Litigation Settlement, Amount Awarded to Other Party

MUSTANG BIO, INC. Litigation Settlement, Amount Awarded to Other Party

MUSTANG BIO, INC. (MBIO) reported Litigation Settlement, Amount Awarded to Other Party of $2.00 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-18.

Discontinued › Notes › Commitment and Contingencies

us-gaap:LitigationSettlementAmountAwardedToOtherParty · last filed 2019-03-18

  • MUSTANG BIO, INC. litigation settlement, amount awarded to other party for the quarter ending 2017-12-31 was -$100.00K.
  • MUSTANG BIO, INC. litigation settlement, amount awarded to other party for fiscal 2017 was $2.00M.
Period endLitigation Settlement, Amount Awarded to Other Party 3 monthLitigation Settlement, Amount Awarded to Other Party 9 monthLitigation Settlement, Amount Awarded to Other Party 12 month
2017-12-31-$100.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
$2.00M
10-K · filed 2019-03-18
2017-09-30$2.10M
10-Q · filed 2017-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
BIOVIE INC. (BIVI)United States$0.012B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B